We proudly present our 2023 annual report, structured around our three strategic goals — developing drugs, developing methods and developing people. Alongside this, the reports includes a range of other stories from around the organisation, celebrating the diverse efforts of our operational and scientific staff.
This year's theme is 'Bridging the Gap'. It has always been our core business to build bridges between preclinical and clinical drug development, and between studies in healthy participants and in patients. The theme is also about building bridges between academic researchers and between academia and pharmaceutical companies.
Read about how we bridged the gap in 2023 here.
